HK1019037A1 - Implantable agarose-collagen beads containing cells which produce a diffusible biological product, and uses thereof - Google Patents

Implantable agarose-collagen beads containing cells which produce a diffusible biological product, and uses thereof

Info

Publication number
HK1019037A1
HK1019037A1 HK99104156A HK99104156A HK1019037A1 HK 1019037 A1 HK1019037 A1 HK 1019037A1 HK 99104156 A HK99104156 A HK 99104156A HK 99104156 A HK99104156 A HK 99104156A HK 1019037 A1 HK1019037 A1 HK 1019037A1
Authority
HK
Hong Kong
Prior art keywords
agarose
biological product
produce
containing cells
beads containing
Prior art date
Application number
HK99104156A
Other languages
English (en)
Inventor
Kanti Jain
Albert L Rubin
Shirin Asina
Barry Smith
Kurt Stenzel
Original Assignee
Rogosin Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/745,063 external-priority patent/US5888497A/en
Application filed by Rogosin Inst filed Critical Rogosin Inst
Publication of HK1019037A1 publication Critical patent/HK1019037A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/04—Enzymes or microbial cells immobilised on or in an organic carrier entrapped within the carrier, e.g. gel or hollow fibres
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/126—Immunoprotecting barriers, e.g. jackets, diffusion chambers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Developmental Biology & Embryology (AREA)
  • Dispersion Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
HK99104156A 1996-04-03 1999-09-24 Implantable agarose-collagen beads containing cells which produce a diffusible biological product, and uses thereof HK1019037A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US62559596A 1996-04-03 1996-04-03
US08/745,063 US5888497A (en) 1996-04-03 1996-11-07 Agarose coated agarose beads containing cancer cells that produce material which suppresses cancer cell proliferation
PCT/US1997/004548 WO1997036495A1 (en) 1996-04-03 1997-03-21 Implantable agarose-collagen beads containing cells which produce a diffusible biological product, and uses thereof

Publications (1)

Publication Number Publication Date
HK1019037A1 true HK1019037A1 (en) 2000-01-21

Family

ID=27089961

Family Applications (2)

Application Number Title Priority Date Filing Date
HK99104156A HK1019037A1 (en) 1996-04-03 1999-09-24 Implantable agarose-collagen beads containing cells which produce a diffusible biological product, and uses thereof
HK04108893A HK1066026A1 (en) 1996-04-03 2004-11-11 Conditioned medium containing a tumor cell proliferation suppressive factor and process of making the same

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK04108893A HK1066026A1 (en) 1996-04-03 2004-11-11 Conditioned medium containing a tumor cell proliferation suppressive factor and process of making the same

Country Status (16)

Country Link
EP (2) EP0914043B1 (de)
JP (2) JP3765039B2 (de)
CN (2) CN1296477C (de)
AT (2) ATE374034T1 (de)
AU (1) AU722109C (de)
CA (1) CA2250880C (de)
DE (2) DE69725317T2 (de)
DK (2) DK0914043T3 (de)
ES (2) ES2290390T3 (de)
FI (1) FI120332B (de)
HK (2) HK1019037A1 (de)
IL (1) IL126442A0 (de)
NO (1) NO320334B1 (de)
NZ (2) NZ331960A (de)
PT (1) PT914043E (de)
WO (1) WO1997036495A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6303151B1 (en) * 1996-04-03 2001-10-16 The Rogosin Institute Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment
US6224912B1 (en) 1996-04-03 2001-05-01 The Rogo Institute Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment
US7297331B2 (en) 1996-04-03 2007-11-20 The Rogosin Institute Beads containing restricted cancer cells producing material suppressing cancer cell proliferation
NO983911D0 (no) 1998-08-26 1998-08-26 Norsk Hydro As Alginatkapsler til bruk ved behandling av hjernesvulst
AU2003264652B2 (en) * 1998-11-09 2006-09-14 The Rogosin Institute Compositions of restricted cells capable of rapid growth which produce proliferation suppressive materials, and uses thereof
US8257715B1 (en) 2004-08-26 2012-09-04 University Of Notre Dame Tissue vaccines and uses thereof
US8802113B2 (en) 2005-10-27 2014-08-12 University Of Notre Dame Extracellular matrix cancer vaccine adjuvant
US8778362B2 (en) 2005-10-27 2014-07-15 University Of Notre Dame Anti-tumor/cancer heterologous acellular collagenous preparations and uses thereof
US9308252B2 (en) 2005-10-27 2016-04-12 Cook Biotech, Inc. Extracellular matrix materials as vaccine adjuvants for diseases associated with infectious pathogens or toxins
US8778360B2 (en) * 2005-10-27 2014-07-15 University Of Notre Dame Extracellular matrix cancer vaccine adjuvant
US9283266B2 (en) 2008-02-28 2016-03-15 University Of Notre Dame Metastasis inhibition preparations and methods
US8846059B2 (en) 2009-12-08 2014-09-30 University Of Notre Dame Extracellular matrix adjuvant and methods for prevention and/or inhibition of ovarian tumors and ovarian cancer
HUE034618T2 (en) * 2012-01-31 2018-02-28 The Rogosin Inst Inc An improved process for producing macros
US20200363402A1 (en) * 2018-02-02 2020-11-19 Wake Forest University Health Sciences Organoids related to immunotherapy and methods of preparing and using the same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE441009B (sv) * 1982-03-08 1985-09-02 Kjell Nilsson Sett att immobilisera levande biomaterial i perlformiga polymerer
US4798786A (en) * 1982-05-06 1989-01-17 Stolle Research And Development Corporation Living cells encapsulated in crosslinked protein
CA1196862A (en) * 1983-06-01 1985-11-19 Anthony M.F. Sun Microencapsulation of living tissue and cells
US4663286A (en) * 1984-02-13 1987-05-05 Damon Biotech, Inc. Encapsulation of materials
SE8604684L (sv) * 1986-11-03 1988-05-04 Excorim Kommanditbolag Sett att belegga fasta partiklar med en hydrofil gel samt genom settet belagda partiklar
JP2691557B2 (ja) * 1988-04-15 1997-12-17 興研株式会社 人の悪性腫瘍細胞増殖抑制剤
US5053332A (en) * 1989-07-24 1991-10-01 Cook Richard B Agarose beads, preferably incorporating biological materials
US5241051A (en) * 1992-04-24 1993-08-31 Research Development Foundation Oncoinhibin
KR100474803B1 (ko) * 1994-01-13 2005-03-10 더 로고신 인스티튜트 거대캡슐화 분비세포
US5651980A (en) * 1994-04-15 1997-07-29 Biohybrid Technologies, Inc. Methods of use of uncoated gel particles

Also Published As

Publication number Publication date
PT914043E (pt) 2004-02-27
ES2206696T3 (es) 2004-05-16
EP1382346B1 (de) 2007-09-26
WO1997036495A1 (en) 1997-10-09
NZ331960A (en) 1999-10-28
JP2001503380A (ja) 2001-03-13
NO320334B1 (no) 2005-11-21
AU722109B2 (en) 2000-07-20
CA2250880A1 (en) 1997-10-09
NZ337109A (en) 2004-12-24
CN1119080C (zh) 2003-08-27
NO984627L (no) 1998-11-30
IL126442A0 (en) 1999-08-17
CA2250880C (en) 2008-01-15
AU722109C (en) 2001-07-19
AU2218897A (en) 1997-10-22
CN1296477C (zh) 2007-01-24
DE69738170T2 (de) 2008-01-24
FI120332B (fi) 2009-09-30
JP4480152B2 (ja) 2010-06-16
CN1495253A (zh) 2004-05-12
FI981957A0 (fi) 1998-09-11
DE69725317D1 (de) 2003-11-06
JP3765039B2 (ja) 2006-04-12
DE69738170D1 (de) 2007-11-08
NO984627D0 (no) 1998-10-02
DE69725317T2 (de) 2004-07-29
ES2290390T3 (es) 2008-02-16
EP0914043B1 (de) 2003-10-01
JP2005104987A (ja) 2005-04-21
ATE374034T1 (de) 2007-10-15
ATE250858T1 (de) 2003-10-15
CN1215309A (zh) 1999-04-28
HK1066026A1 (en) 2005-03-11
DK0914043T3 (da) 2004-02-09
DK1382346T3 (da) 2008-01-28
FI981957A (fi) 1998-12-02
EP0914043A4 (de) 2001-08-29
EP1382346A1 (de) 2004-01-21
EP0914043A1 (de) 1999-05-12

Similar Documents

Publication Publication Date Title
HK1019037A1 (en) Implantable agarose-collagen beads containing cells which produce a diffusible biological product, and uses thereof
AU571060B2 (en) High porosity body used for adsorption or absorption purposesparticularly for animal litters, method for producing it and utilization thereof
DE68907611D1 (de) Auf teilchen immobilisierte lipasezubereitung, verfahren zur herstellung und deren verwendung.
AU3862097A (en) Catalytic nucleic acid and its medical use
AU7934582A (en) Use of polyethylene imine as absorbant for odorous substances
PT1382346E (pt) Meio condicionado e produto biológico difusível produzido por incubaçâo de células aprisionadas
AU1166895A (en) Polysubstituted 3-acylamino-5-phenyl-1,4-benzodiazepin-2-onederivatives, process for their preparation and the pharmaceutical compositions containing them
IE830945L (en) Process for obtaining permanently culturable animal and¹human cell lines
AU6372496A (en) Absorbent material, absorbent body made of the material, and method for the preparation of the material
DE3576361D1 (de) Rekombinante dna, damit transformierter mikroorganismus, und verfahren zur herstellung von menschlicher cu-zn superoxiddismutase unter verwendung des transformierten mikroorganismus.
HUP0000868A2 (en) Solid culture medium for microorganisms, process for its preparation, and use
AU1828388A (en) Promoters for the expression of foreign dna in methylotrophic bacteria, the obtaining thereof and the use thereof
AU576957B2 (en) Catalyst comprising zeolite, platinum, with iron, cobalt or titanium
EP0222289A3 (en) Process for the immobilization of biological material, particulate coagulates containing an immobilized biological material and their use as catalysts
EP0112299A3 (de) Verfahren zur Reinigung von Superoxid-Dismutase mittels Affinitätschromatographie
AU2371397A (en) Substituted 1-naphthoylguanidines, process for their preparation, their use as medicament or diagnostic, and medicament containing them
EP0776968A4 (de) Flüssigmedium für nervenzellen, verfahren für dessen herstellung und eine methode für die inkubation von nervenzellen unter verwendung desselben
GB8830075D0 (en) Non-attritive method for making polyethylene particles,particles obtainable by the method and their use
AU3845395A (en) Antibodies against allogenic and xenogenic proteins, their use in diagnosis and therapy and methods for the determination thereof
AU1939697A (en) Physiologically active substances tkr1785's, process for the preparation thereof, and microbe
AU3489095A (en) Filter for tobacco smoke
AU5085490A (en) Dynamic flow cell culture system
EP0598269A3 (en) Apparatus for the culture of living cells and tissues.
AU4613996A (en) Fillers for biological exhaust air purification, process for their preparation, their use and bioreactors containing them
ATE74968T1 (de) Eukaryotische fusionsproteine, ihre herstellung und verwendung sowie mittel zur durchfuehrung des verfahrens.

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20160321